Efficacy of cooling-vacuum assisted 1540 nm erbium-doped glass laser (Er:Glass) in mild-to-moderate acne

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Acne is a common skin disease that affects millions of people around the world. There are several options for acne treatment: the application of local anti-acne agents often has limited effectiveness, and systemic treatment carries the risk of significant side effects. Sources of visible, infrared and laser radiation have become common physical methods of treating acne.

AIMS: to evaluate the effectiveness and safety of an erbium laser on glass (1540 nm) with integrated cooling and vacuum amplification for the treatment of mild-to-moderate acne

MATERIALS AND METHODS: We observed twelve patients (seven men and five women) from 17 to 27 years old (average age 19±1.6) with Fitzpatrick skin type II to IV. Acne severity was assessed using the Investigator’s Assessment Scale (IGA). 5 patients had mild acne (IGA 2) and 7 had moderate acne (IGA 3). Patients were treated with an erbium laser on glass using the mid-infrared region of the spectrum, with a wavelength of 1540 nm (Harmony XL, Alma Lasers Ltd.), 4 to 6 procedures were performed every 2 weeks. The number of sessions was determined by clinical improvement.

RESULTS: All 12 patients completed treatment (from four to six procedures, mean value 4.6±0.4) and were observed 1 and 3 months after the last session. The improvement in the appearance of the skin occurred gradually. Clear (IGA 0) or almost clear (IGA 1) skin were achieved in all patients. The subjective assessment of patient satisfaction ranged from “satisfied” (four patients) to “very satisfied” (eight patients) during the last visit. Side effects were mild and included mild erythema and edema in all patients, their severity and the percentage of patients suffering from them decreased during treatment. No edema was observed during follow-up visits after 1 and 3 months.

CONCLUSIONS: The study proves the effectiveness and safety of the cooling-vacuum assisted 1540 nm erbium-doped glass laser (Er:Glass) in mild-to-moderate acne. Further studies with a larger number of participants and a longer follow-up period are needed to establish long-term efficacy.

Full Text

Restricted Access

About the authors

Igor Ya. Pinson

Clinic “Presidentmed”

Author for correspondence.
Email: iddp@yandex.ru
SPIN-code: 7244-0086

MD, Dr. Sci. (Med.), Professor

Russian Federation, 3, Sivtsev vrazhek per., Moscow, 119019

Irina V. Verchoglyad

Clinic “Presidentmed”

Email: ons-10@yandex.ru

MD, Dr. Sci. (Med.)

Russian Federation, 3, Sivtsev vrazhek per., Moscow, 119019

Ekaterina M. Anpilogova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: truelass@hotmail.com
ORCID iD: 0000-0001-9478-5838
SPIN-code: 8499-0506

MD

Russian Federation, Moscow

References

  1. Kircik LH. Advances in the understanding of the pathogenesis of inflammatory acne. J Drugs Dermatol. 2016;15(1 Suppl 1):s7–10.
  2. Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2021;32(3):277–285. doi: 10.1080/09546634.2019.1654075
  3. Tan JK, Gold LF, Alexis AF, Harper JC. Current concepts in acne pathogenesis: pathways to inflammation. Semin Cutan Med Surg. 2018;37(3S):S60–S62. doi: 10.12788/j.sder.2018.024
  4. Borovaya A, Olisova O, Ruzicka T, Sardy M. Does isotretinoin therapy of acne cure or cause depression? International Journal of Dermatology. 2013;52(9):1040–1052. doi: 10.1111/ijd.12169
  5. Hauk L. Acne vulgaris: treatment guidelines from the AAD. Am Fam Physician. 2017;95(11):740–741.
  6. Wiznia LE, Stevenson ML, Nagler AR. Laser treatments of active acne. Lasers Med Sci. 2017;32(7):1647–1658. doi: 10.1007/s10103-017-2294-7
  7. Olisova OYu, Vladimirova EV, Babushkin AM. The skin and the sun. Russ J Skin Venereal Dis. 2012;15(6):57–62. (In Russ).
  8. Perper M, Tsatalis J, Eber AE, et al. Lasers in the treatment of acne. G Ital Dermatol Venereol. 2017;152(4):360–372. doi: 10.23736/S0392-0488.17.05641-3
  9. Politi Y, Levi A, Snast I, et al. Integrated cooling-vacuum-assisted non-fractional 1540 nm erbium:glass laser: a new modality for the simultaneous effective treatment of acne lesions and scars. J Drugs Dermatol. 2018;17(11):1173–1176.
  10. Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne. Cochrane Database Syst Rev. 2016;9(9):CD007917. doi: 10.1002/14651858.CD007917.pub2
  11. Li MK, Liu C, Hsu JT. The use of lasers and light devices in acne management: an update. Am J Clin Dermatol. 2021;22(6):785–800. doi: 10.1007/s40257-021-00624-5
  12. Politi Y, Levi A, Lapidoth M. Integrated cooling-vacuum-assisted non-fractional 1540 nm erbium:glass laser is effective in treating acne scars. J Drugs Dermatol. 2016;15(11):1359–1363.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Erbium laser on glass (Er:Glass) with cooling and vacuum amplification, wavelength of 1540 nm (Harmony XL, Alma Lasers Ltd., Israel).

Download (239KB)
3. Fig. 2. Patient A., 23 years old. Acne of moderate severity: a–c ― appearance before treatment; d ― during treatment; e ― after treatment.

Download (451KB)
4. Fig. 3. Patient S., 20 years old. Acne of mild severity: a ― before treatment; b ― after treatment.

Download (189KB)

Copyright (c) 2022 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies